I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy of erlotinib as first-line maintenance therapy in ..:
Senthil Rajappa
;
Dinesh Chandra Doval
;
Jaydip Biswas
...
http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=1;spage=1;epage=5;aulast=Rajappa. , 2017
Link:
https://doi.org/10.4103/2278-330X.202573
RT Journal T1
Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:6f2750eda4244b4eb015fa7695addca3&Exemplar=1&LAN=DE A1 Senthil Rajappa A1 Dinesh Chandra Doval A1 Jaydip Biswas A1 Shekar Patil A1 Naresh Somani A1 Sankar Srinivasan A1 Shailesh Bondarde A1 Nitin S Palwe A1 Binay Swarup PB Thieme Medical and Scientific Publishers Pvt. Ltd. YR 2017 K1 Epidermal growth factor receptor-tyrosine kinase inhibitor K1 first-line maintenance therapy K1 nonsmall cell lung cancer K1 progression-free survival rate K1 targeted therapy K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=1;spage=1;epage=5;aulast=Rajappa LK http://dx.doi.org/https://doi.org/10.4103/2278-330X.202573 DO https://doi.org/10.4103/2278-330X.202573 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)